Function Therapeutics, Inc.
Publicly observedMilwaukee, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Milwaukee | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Function Therapeutics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | DMN7SCPC2TR5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant11 Sept 2025Publicly observed
NIH SBIR/STTR award: Parmodulins without Abuse Potential for the Treatment of Neuropathic Pain
USD 200,070.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant11 Sept 2025Publicly observed
NIH SBIR/STTR award: Parmodulins without Abuse Potential for the Treatment of Neuropathic Pain
USD 499,863.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant15 Aug 2024Publicly observed
NIH SBIR/STTR award: Small Molecule PAR1 Ligands for the Treatment of MASH
USD 39,740.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant15 May 2024Publicly observed
NIH SBIR/STTR award: Inhibitors of Thromboinflammation for Acute Kidney Injury
USD 88,907.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.